| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cll1-cd33 ccart cell therapy | myeloid cell surface antigen cd33 | NA | Successful target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
NA | phase 1 | unknown |
| cll1-cd33 ccart cell therapy | myeloid inhibitory c-type lectin-like receptor | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Leukemia Myelocytic Acute[MeSHID:D015470] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||